Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Aminophylline hydrous |
Is a |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Aminophylline anhydrous |
Is a |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Accidental aminophylline poisoning |
Causative agent |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Intentional aminophylline poisoning |
Causative agent |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Forgiftning med aminofyllin, uvist med hvilken hensigt |
Causative agent |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline adverse reaction |
Causative agent |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Allergy to aminophylline |
Causative agent |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Aminophylline overdose |
Causative agent |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Accidental aminophylline overdose |
Causative agent |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Intentional aminophylline overdose |
Causative agent |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
overdosis af aminophyllin, uvist med hvilken hensigt |
Causative agent |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
aminophyllin 25 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
aminophyllin 225 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
aminophyllin 350 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
aminophyllin 100 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
aminophyllin 25 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Aminophylline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
aminophyllin 25 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
aminophyllin 25 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
aminophyllin 250 mg/10 ml injektionsvæske, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
aminophyllin tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Aminophylline-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline 250 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Product containing precisely aminophylline 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Aminophylline 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
aminophyllin 105 mg/5 ml oral væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Aminophylline hydrate |
Is a |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Product containing aminophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Poisoning by aminophylline |
Causative agent |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
aminophyllinhydrat tablet med modificeret udløsning a 350 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
aminophyllinhydrat tablet med modificeret udløsning a 225 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
aminophyllinhydrat tabletter med modificeret udløsning a 100 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Aminophylline measurement (procedure) |
Component |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline blood measurement |
Component |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
2 |
Serum aminophylline measurement |
Component |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
2 |
Accidental aminophylline poisoning |
Causative agent |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Intentional aminophylline poisoning |
Causative agent |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline hydrate |
Is a |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Allergy to aminophylline |
Causative agent |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline 100mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Aminophylline 350mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Aminophylline hydrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Aminophylline anhydrous |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
|
Product containing precisely aminophylline 225 milligram/1 each prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aminophylline 225 milligram/1 each prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aminophylline 250 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aminophylline 250 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aminophylline 250 milligram/10 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aminophylline 250 milligram/10 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing only aminophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aminophylline 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aminophylline 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aminophylline 500 milligram/1 each conventional release rectal suppository (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aminophylline 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline 250 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline 250 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Aminophylline blood measurement |
Component |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |
Serum aminophylline measurement |
Component |
True |
Aminophylline (substance) |
Inferred relationship |
Some |
1 |